Methylation analyses using home-based self-sampling in women with and without gynecological disease
Official title: Methylation Analyses for Gynaecological Research Through Home-based Self-sampling
Run by Universiteit Antwerpen · NCT07902388 · Data updated 2026-11-12
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 512 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 1 site (Edegem, Antwerp) |
| Status | Recruiting |
| Started | April 13, 2026 |
| Main results expected | December 31, 2032 |
| Study ends | December 31, 2032 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07902388 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women and people with female genital organs aged 18 or older, Belgian nationality, who can provide informed consent and perform self-sampling.
✕Probably not a fit
Individuals who have a history of gynecological cancer, are pregnant or postpartum within 6 months, or cannot perform self-sampling may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The MARGOT study collects self-sampled first-void urine and vaginal material from adults to compare biomarker patterns with samples from individuals diagnosed with gynecological (pre-)cancers. Cancer-free controls are recruited through social media, volunteer databases, and healthcare posters, and may collect samples at home or at the study center. A questionnaire gathers information on risk factors and experiences with self-sampling while samples are analyzed using the Colli-Pee device with UCM and Evalyn Brush. The study aims to better understand differences in biological markers between these groups and to validate reference populations for future biomarker research. This is an interventional study with self-sampling as the core procedure, conducted at the University of Antwerp and affiliated centers.
Why it matters
Potential benefit: If successful, participants could contribute to improved screening methods for gynecological cancers based on self-collected samples.
How similar studies have gone: Previous biomarker and methylation analyses using self-samples have shown promise, but this exact home-based self-sampling approach combines novel elements and reference controls.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals having female genital organs, regardless of their gender identity. * Participant is 18 years or older at the time of signing the informed consent form. * Participant must be able to understand the (Dutch) information consent form and what the study is about. * Participant must be able to provide written informed consent and take urine- and vaginal self-samples. * Individual has a Belgian nationality. Exclusion Criteria: * Individuals that underwent hysterectomy or ovariectomy. * Pregnant individuals or 6 months post-partum. * (History of) (pre)cancer, or an ongoing diagnostic work-up or treatment for oncological concerns. * Unable to give informed consent or to take urine- or vaginal self-samples. * Participation in another interventional study. However, participation in another low-interventional or observational study is allowed. * Individuals who have (a history) of postmenopausal bleeding.
Where it's running
-
University of Antwerp, Center for the Evaluation of Vaccination, Vaccinopolis
Edegem, Antwerp, Belgium Recruiting
Study contacts
- Principal investigator: Wiebren A.A. Tjalma, MD, PhD — Universiteit Antwerpen
- Study coordinator: Tine Pinxteren, MSc
- Email: tine.pinxteren@uantwerpen.be
- Phone: 476014843
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
-
Slow-paced breathing to boost heart rate variability in healthy young adults
This study tests whether a 6-week slow-paced breathing program can improve heart rate variability and lower perceived stress in healthy young adults with dysfunctional breathing patterns.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.